ALBO
Albireo Pharma Inc
A biopharmaceutical company that develops medicines for rare liver diseases, especially in children. Its lead product, Bylvay (odevixibat), is an oral capsule that eases the severe itching caused by bile acid buildup in rare genetic liver conditions. Founded in 2008 as a spinout from AstraZeneca, the company takes its name from Albireo, a famous double star in the Cygnus constellation that appears as one point of light but resolves into two colorful stars through a telescope. It became part of the global drugmaker Ipsen in 2023.
CUSIP: 01345P106HealthcareUS2 holders
Total Value
$20.26M
Total Shares
937.4K
Net Share Change
-4.6K
Activity
1 selling
Investor
Value
Shares
Weight
Change
